Clinical Trial Update: A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial evaluating four doses of indacaterol delivered by the TWISTHALER in adults and adolescents with persistent asthma; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-01-18